Form 4: Hologic Executive Mark Horvath Boosts Stake

Hologic's President of Breast & Skeletal, Mark W. Horvath, acquired 2,278 shares of common stock through performance unit vesting.

Summary

• Mark W. Horvath, President, Breast & Skeletal at Hologic Inc. (HOLX), acquired 2,278 shares of common stock.
• The acquisition occurred on November 4, 2025, and was related to performance stock units where performance criteria have been satisfied.
• These units remain subject to service-based vesting requirements and settle on a one-for-one basis into common stock.
• Following this transaction, Mr. Horvath beneficially owns 9,681 shares of Hologic common stock.
• This total includes 346 shares acquired via the employee stock purchase plan and 2,327 restricted stock units deferred under the company's Deferred Equity Plan.
• The transaction was made pursuant to a Rule 10b5-1 plan.

Sentiment

Score: 7

Explanation: The filing indicates an executive increasing their stake in the company through the vesting of performance units, which is generally a positive signal of management alignment and confidence, even if it's a routine compensation event.

Positives

• Mark W. Horvath, a key executive, increased his beneficial ownership in Hologic Inc. by 2,278 shares.
• The acquisition stems from performance stock units where the performance criteria have been satisfied, indicating successful achievement of company goals.
• The transaction was conducted under a Rule 10b5-1 plan, demonstrating pre-planned and compliant insider trading.
• Increased insider ownership can signal management's confidence in the company's future prospects.

Risks

• The acquired performance stock units remain subject to service-based vesting requirements, meaning full ownership is contingent on continued employment.

Future Outlook

Not applicable, as this Form 4 reports a past insider transaction and does not contain forward-looking statements or guidance.

Industry Context

This Form 4 filing details a routine insider transaction and does not provide information relevant to broader industry trends or competitor analysis.

Corporate Governance

Stakeholder Impact

• Shareholders: Potentially positive, as increased insider ownership can align management interests with shareholder interests.
• Employees: The mention of an employee stock purchase plan and deferred equity plan indicates existing compensation structures that benefit employees.

Key Dates

Recommendation

This Form 4 reports a routine executive stock acquisition through the vesting of performance units, which is a minor positive signal of management alignment. It does not provide sufficient new information to warrant a change in investment recommendation, but rather confirms ongoing executive compensation practices.

Keywords

Hologic, HOLX, Form 4, insider transaction, stock acquisition, executive compensation, performance stock units, Rule 10b5-1